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1. Introduction
In cases of drug-resistant unilateral mesial temporal lobe epilepsy
(MTLE) due to hippocampal sclerosis, standard anterior temporal lobec-
tomy (ATL) may result in seizure freedom in over 65% of cases [1–5].
Complications from standard ATL are relatively uncommon. However, in
less than 6% of cases complications could include stroke, subdural hema-
toma, new neurologic deficits, postoperative infections, and/or cognitive
and behavioral changes [5]. The use of post-operative corticosteroids
may mitigate post-operative symptoms, e.g., headache, and limit other
complications [6–8]. In individuals with diabetes, caution must be
employed when using corticosteroids to reduce complications related to
elevated blood glucose. One common presentation of nonketotic hyper-
glycemic states is focal motor status epilepticus or epilepsia partialis con-
tinua (EPC) [9–12]. However, post-operative corticosteroid-induced focal
motor status epilepticus following standard ATL has been less commonly
described. This case report describes a patient with postoperative
nonketotic hyperglycemic induced focal motor status epilepticus related
to treatment with corticosteroids following standard ATL.
2. Case Report
A 31-year-old right-handed woman presented to the Henry Ford
Health System Comprehensive Epilepsy Program with a history of
drug-resistant focal epilepsy. Her index seizure was a focal to bilateral
tonic–clonic seizure at the age of 15 years old that occurred in
the setting of eclampsia. She was placed on a trial of levetiracetam
and remained seizure-free until the age of 23 years old when she
experienced a focal impaired awareness seizure. Following this
seizure, her seizures remained resistant to anti-seizure drug trials of
levetiracetam, lamotrigine, clobazam, zonisamide, lacosamide, carba-
mazepine XR, and perampanel.
Her habitual seizures began with a feeling of nausea or a rising
sensation in her abdomen. After this she would lose awareness during
which time manual and oral automatisms would occur. Additionally,
ictal spitting could be present. On rare occasions her focal seizures
could evolve to a bilateral tonic–clonic seizure with versive headmove-
ments to the right and left upper extremity tonic posturing.
Her noninvasive diagnostic studies, including inpatient video-EEG
monitoring, brain MRI, FDG-PET, and neuropsychology testing, were
concordant and implicated an epileptogenic zone within the right
temporal lobe (Figs. 1–3). In light of these findings, a right standard
ATL was completed (Fig. 4). Her immediate post-operative course was
uncomplicated, and she was discharged home on the second post-
operative day. At discharge, her anti-seizure medication regimen
consisted of lacosamide 200mg in the morning and 300mg at bedtime
and perampanel 6 mg at bedtime. She was also placed on dexametha-
sone 4 mg every 6 h with a tapering schedule of 4 mg every 3 days for
12 days followed by 2 mg daily for 3 days before discontinuing this
treatment. Her anti-seizuremedicationswere not tapered after surgery,
and she initially tolerated treatment with dexamethasone well without
adverse reactions.
Then approximately oneweek following her discharge, she began to
experience seizures that were different than her habitual seizures.
These new seizures consisted of frequent, brief focal motor seizures
characterized by repetitive left hemi-facial contractionswithout impair-
ment of awareness. She was urgently admitted to Henry Ford Hospital
for further evaluation and management. A repeat brain MRI demon-
strated postsurgical changes in the right anterior temporal lobewith ad-
jacent increased T2/FLAIR signal along the superior and posterior
resection cavity (Fig. 4A-C). Continuous video-EEGmonitoring revealed
focal motor status epilepticus with seizures arising from the right
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fronto-central region (Figs. 5 and 6). She continued to experience ap-
proximately 17 seizures every 6 hours and a loading dose levetiracetam
with escalating doses of lacosamide and perampanel were unsuccessful
in controlling her seizures.
Review of her laboratory findings revealed markedly elevated blood
glucose of 445mg/dL (range 50–150). Prior to surgery her blood glucose
was 136 mg/dL and at discharge from HFH her blood glucose was
113mg/dL (Table 1). During this admission, she relayed a prior diagno-
sis of type II diabetes mellitus that resolved following 200-pound
weight loss approximately 10 years prior. Upon further review, she
also required treatment for gestational diabetes with metformin two
years prior to ATL.
Fig. 1. Interictal EEG; Right temporal sharp-and-wave discharge during stage 2 sleep. AP bipolar montage, TC 0.3, HFF 70 Hz, Sen 7 uV.
Fig. 2. Ictal EEG; Right temporal lobe seizure, 30 seconds after clinical onset. AP bipolar montage, TC, 0.1, HFF 70 Hz, Sen uV.
125A. Zillgitt et al. / Epilepsy & Behavior Case Reports 10 (2018) 124–128
With aggressive control of her blood glucose, including a trial of
metformin and discontinuation of dexamethasone, her new seizures im-
proved and subsequently resolved. She had no recurrent focal motor sei-
zures after this and she has been free of her habitual seizures for over
3 years.
3. Discussion
In this case, a woman with drug resistant focal epilepsy had concor-
dant noninvasive diagnostic testing that implicated an epileptogenic
zone within the right temporal lobe. Following a right standard ATL
she experienced a new seizure-type that occurred in the setting of
treatment with dexamethasone. She subsequently disclosed a prior
diagnosis of type II diabetes mellitus that had previously beenmanaged
with weight loss and exercise. After aggressive control of her blood glu-
cose, these new seizures decreased in frequency and resolved. She has
remained free of her habitual focal impaired awareness seizures and
her postoperative focal motor seizures for over 3 years.
Focal motor status epilepticus or EPC are common and often
the presenting sign in nonketotic hyperglycemic states [12,13]. Interest-
ingly, in this case the focal motor seizures arose from the same hemi-
sphere as the resection site. Although this may raise concerns for an
independent seizure onset zone or false localization of the hypothesized
presurgical epileptogenic zone, one case series of 22 patients with EPC
in the setting of hyperglycemia identified a structural lesion in the
majority of subjects [13]. In this case, it would be less likely these
Fig. 3. A-B – Preoperative brain MRI (coronal FLAIR sequence); there is atrophy, loss of internal architecture, and increased FLAIR signal within the right mesial temporal structures and
hippocampus.
Fig. 4.A-C – Post-operative brainMRI (A – coronalmagnetization-prepared rapid gradient-echo (MP-RAGE), B – axial MP-RAGE, C – sagittalMP-RAGE); there are post-surgical changes in
the right temporal lobe without obvious structural abnormalities within the adjacent right frontal and temporal lobes.
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seizureswere due to perioperative focal seizure aggravation in the fron-
tal neocortex with asymptomatic glucose elevation. Rather, in the set-
ting of a structural abnormality, hyperglycemia from treatment with
dexamethasone could have contributed to the onset of postoperative
focal motor status epilepticus.
Early seizure recurrence after epilepsy surgery may suggest failure
to adequately resect or disconnect the epileptogenic zone [14]. How-
ever, the seizures in this caseweremarkedly different thanher preoper-
ative seizure semiology. Additionally, early studies reviewing criteria for
localizing an epileptogenic focus reported focal functional deficits
Fig. 5. Post-operative ictal EEG; Right fronto-central seizures, 15 seconds after EEG and clinical onset. AP bipolar montage, TC 0.1, HFF 70 Hz, Sen 7 uV.
Fig. 6. Post-operative ictal EEG density spectral array (DSA) trend; there was a total of 17 focal motor seizures over this 6-hour time period; TC 0.1, HFF 70 Hz, Sen 7 uV.
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provided beneficial nonconflicting confirmatory information [15].
In this regard, FDG-PET could be useful in the epilepsy presurgical
evaluation. A review of epilepsy networks by Spencer in 2002 noted
hypometabolism on FDG-PET is a consistent finding in MTLE and its ab-
sence should raise doubt to accurate localization of an epileptic network
within the medial temporal structures [16]. Therefore, if there was no
hypometabolism within the right temporal lobe on FDG-PET, consider-
ation should be given to an epileptic network outside of this region. This
was not the case in this patient where FDG-PET demonstrated
hypometabolism within the right temporal lobe.
A recent prospective study evaluated the utility of inpatient video-
EEG monitoring in people with suspected MTLE associated with unilat-
eral MTS [17]. In this study, there was no difference in seizure outcome
after surgery between the groups who had video-EEG monitoring and
thosewhodid not. The authors suggested it could be safe to recommend
epilepsy surgery without inpatient video-EEG monitoring in people
with MTLE with unilateral MRI signs of MTS, clinical semiology consis-
tent with MTLE, no suspicion of nonepileptic events, and adequate out-
patient EEGswith lateralized interictal epileptiform activity toMTS [17].
The patient in this case demonstratedmany of these characteristics, and
this would strengthen the hypothesis of right MTLE as opposed to an
epileptic network within the right frontal central region.
Despite the concordant noninvasive diagnostic testing implicating
an epileptogenic zonewithin the rightmesial temporal lobe, “secondary
epileptogenesis” could produce an independent, de novo, epileptogenic
focus. However, this phenomenon has not been described in the
hyperacute post-operative period [14]. In fact, secondary epileptogenesis
is believed to be a phenomenon that occurs often over 12 months after
epilepsy surgery [14].
Therefore, in light of a preoperative seizure semiology consistent
with mesial temporal lobe seizures, unilateral right MTS on structural
brain MRI, the presence of right temporal lobe hypometabolism on
FDG-PET, and markedly different seizure semiology between pre- and
post-operative seizures, a diagnosis of right MTLE is favored over an
overlooked epileptic network within the right frontal central sulcus.
Furthermore, the improvement in her seizure frequency after blood glu-
cose control would suggest the new seizures in this caseweremost likely
related to elevated blood glucose from treatment with dexamethasone.
Overall, complications from epilepsy surgery, and particularly ATL,
are relatively uncommon. Previous studies have estimated complication
rates around 6–10% in all surgical cases, and more recent studies have
suggested the complication rates may be significantly lower at high-
volume, compared to low-volume, epilepsy surgical centers [3–5,7,8].
However, a recent review of CMS Part B data and the National
Surgical Quality Improvement Program (NIQSIP) database, reported
complications in nearly 18% of surgical cases [7]. Complications were
more common in older individuals, male gender, those with higher
American Society of Anesthesiologists (ASA) classification, and in
those people with a pre-existing bleeding disorder [7]. The most
common complication was a return to the operating room (primarily
for hemorrhage), but complications ranged from death and cardiac arrest
to septic shock and deep vein thrombosis [7].
Treatment with corticosteroids following ATL dates back to the
1960's [6]. The use of corticosteroids may reduce cerebral edema and
other perioperative complications. However, the use of corticosteroids
in people with diabetes mellitus may result in elevated blood glucose
and serum osmolality. In cases of nonketotic hyperglycemic states,
seizures, and specifically focalmotor seizures,may be common and a pre-
senting feature [9–12]. The mechanism behind seizures due to elevated
blood glucose and serum osmolality is poorly understood, but some stud-
ies have suggested glucose is a “pro-convulsant,” [12]. Interestingly, 20
people had comorbid diabetesmellitus, and an additional 35were receiv-
ing chronic steroids [7]. Six of the 20peoplewith comorbiddiabetes expe-
rienced complications, while ten out of thirty-five people with chronic
steroid use also had a complication [7]. There was no report of focal
motor status epilepticus or EPC in this database review [7].
Conclusions
This case demonstrates a previously unreported potential complica-
tion following an ATL. Overall, complications after ATL are relatively
rare, and corticosteroidsmaymitigate some postoperative complications.
In people undergoing epilepsy surgery, corticosteroids should be used
cautiously in people with comorbid diabetes mellitus to avoid nonketoic
hyperglycemic states. Aggressive blood glucose control in the post-
operative period may reduce surgical complications and the potential
for post-operative corticosteroid-induced focal motor status epilepticus.
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Table 1
Serum glucose pre-and-post right standard ATL.
Date Serum glucose
3 months prior to surgery 136 mg/dL (range 50–140)
Day of surgery 176 mg/dL (range 50–140)
2 weeks post right standard ATL 445 mg/dL (range 50–140)
3 weeks post right standard ATL after treatment 113 mg/dL (range 50–140)
6 months post right standard ATL
(treatment with metformin)
106 mg/dL (range 60–99)
30 months post right standard ATL
(treatment with metformin)
121 mg/dL (range 60–99)
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